Q1 26 EPS
$0.18
BEAT +24.83%
Est. $0.14
Q1 26 Revenue
$585.5M
BEAT +2.81%
Est. $569.5M
vs S&P Since Q1 26
-5.8%
TRAILING MARKET
CLVT -1.1% vs S&P +4.7%
Market Reaction
Did CLVT Beat Earnings? Q1 2026 Results
Clarivate PLC posted a stronger-than-expected first quarter, with adjusted diluted EPS of $0.18 topping the $0.14 consensus estimate and marking the company's fourth consecutive quarter of beating analyst expectations, while revenue of $585.50 millio… Read more Clarivate PLC posted a stronger-than-expected first quarter, with adjusted diluted EPS of $0.18 topping the $0.14 consensus estimate and marking the company's fourth consecutive quarter of beating analyst expectations, while revenue of $585.50 million cleared the $568.78 million Wall Street forecast by a comfortable margin. The headline revenue figure declined from $593.70 million a year ago, but that drop was driven entirely by strategic divestitures in the Academia & Government and Life Sciences & Healthcare segments rather than underlying demand erosion, with organic revenue actually growing 0.6%. The more telling signal was adjusted EBITDA margin expanding 190 basis points to 41.2%, as Clarivate's Value Creation Plan translated organic growth into meaningful cost discipline. A net loss of $40.20 million narrowed sharply from $103.90 million in the prior-year period, aided by foreign exchange benefits and lower restructuring charges. Management reaffirmed full-year 2026 guidance, targeting revenues of $2.30 billion to $2.42 billion, adjusted diluted EPS of $0.70 to $0.80, and free cash flow of $365.00 million to $435.00 million, with 2026 expected to mark the final year of revenue decline.
Key Takeaways
- • Organic subscription revenue growth of 1.7%, accelerating 230 bps YoY, driven by new customer wins and pricing
- • Adjusted EBITDA margin expanded 190 bps to 41.2% from cost discipline and organic growth
- • Organic ACV growth of 1.6% reflecting improved product pricing
- • Total recurring revenue growth of 1.0% organically
- • Over 600 new ProQuest subscriptions sold since launch
- • ~100 bps improvement in Q1 IP renewal rate
CLVT Forward Guidance & Outlook
Clarivate reaffirmed its full-year 2026 financial outlook: Revenues of $2.30B to $2.42B; Organic ACV growth of 2.0% to 3.0%; Recurring organic revenue growth of 0.75% to 2.25%; Adjusted EBITDA of $980M to $1.04B with margins of 42.0% to 43.5%; Adjusted diluted EPS of $0.70 to $0.80 (based on ~650 million diluted shares); Free cash flow of $365M to $435M. The revenue decline is expected to be driven entirely by strategic disposals, with 2026 expected to be the final year of decline. Management expects ACV organic growth to accelerate through the balance of the year, with margin expansion driven by organic growth and cost discipline. The company plans to repurchase $300M of 2028 notes through the rest of the year and targets deleveraging from 4.0x to approximately 2.5x net leverage over the next three years. Guidance does not include the potential sale of the LS&H business.
CLVT YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
CLVT Revenue by Segment
With YoY comparisons, source: SEC Filings
“We are off to a solid start to 2026, with first-quarter results demonstrating tangible progress against the Value Creation Plan we launched in early 2025. Execution of the VCP is strengthening the quality and durability of our performance. We are simplifying and optimizing our business model, improving commercial effectiveness, and accelerating innovation across the portfolio. Together, these actions are expanding margins, increasing free cash flow generation, and improving the consistency of our results. AI is becoming a meaningful enabler of this progress, embedded in our products to enhance customer workflows and decision-making, and deployed internally to drive efficiency and scalability. With a more focused strategy and continued execution discipline, we remain confident in our ability to deliver sustainable growth and long-term value for shareholders.”
— Matti Shem Tov, Q1 2026 Earnings Press Release
CLVT Earnings Trends
CLVT vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CLVT EPS Trend
Earnings per share: estimate vs actual
CLVT Revenue Trend
Quarterly revenue: estimate vs actual
CLVT Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.14 | $0.18 | +24.83% | $585.5M | +2.81% |
| Q4 25 BEAT FY | $0.16 | $0.20 | +22.25% | $617.0M | +2.02% |
| FY Full Year | $0.66 | $0.69 | +5.33% | $2.46B | +0.50% |
| Q3 25 BEAT | $0.16 | $0.18 | +15.09% | $623.1M | +9.25% |
| Q2 25 BEAT | $0.17 | $0.18 | +3.39% | $621.4M | +5.44% |
| Q1 25 BEAT | $0.12 | $0.14 | +20.69% | $593.7M | +4.09% |